VYNE Therapeutics Inc.VYNENASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR-21.1%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-21.1%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 33.52% |
| 2024 | -40.00% |
| 2023 | -22.59% |
| 2022 | 68.35% |
| 2021 | 71.31% |
| 2020 | -262.69% |
| 2019 | -36.97% |
| 2018 | -76.93% |
| 2017 | -106.68% |
| 2016 | -205.30% |